KCT0006081招募中未知
A randomized clinical trial to evaluate the safety and effectiveness of the full-veneer crown fabricated with a 3D printed resin material for definitive prosthesis
Yonsei University Health System, Dental Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •Patients over 19 years of age
- •Patients who have signed consent for clinical research
- •Patients requiring single fixed posterior prosthetic treatment
- •Patients without non-functional movements such as teething
- •Patients without jaw joint and other occlusal disorders
- •Patients whose opposing teeth are natural teeth
排除标准
- •Patients unable to read the consent
- •Patients with uncontrolled systemic disease
- •Patients with active lesions or symptoms on the tooth being restored
- •patients with hypersensitivity to zirconia or resin materials
- •patients who Inappropriate participation at the discretion of the principal investigator as it can affect the outcome of other ethical or clinical studies
研究者
相似试验
尚未招募
不适用
A clinical trial to study the safety and practicability of mono polar urethral route removal of prostate without post-surgery urinary catheter traction in patients with enlarged prostateCTRI/2022/01/039199Abhineeth K P
进行中（未招募）
不适用
Evaluation of the safety and effectiveness of esmolol and metoprolol for heart rate reduction during heart CT examinatioHeart rate control of patients referred to coronary computed tomography angiography (CCTA) due to suspected coronary artery disease are to investigated with esmolol and metoprolol. Acquiring diagnostic image quality with CCTA requires relative low and stable heart rate of the patients during examination. Thus, heart rate control with beta-blocker medication (esmolol, metoprolol) is recommended. However no current guideline is available regarding esmolol administration during CCTA.MedDRA version: 14.1Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2013-000048-24-HUHear Center of Semmelweis University
已完成
Unknown
A Prospective Randomized Clinical Trial to Validate Atrial Fibrillation Substrate Ablation for Non-Paroxysmal Atrial Fibrillatioatrial fibrillationJPRN-UMIN000051524Tsuchiura Kyodo General Hospital130
尚未招募
2 期
se of Olaparib, a drug that inhibits an enzyme linked to inflammatory response and DNA repair, in sepsisseptic shockRBR-8xdc8yzEscola Paulista de Medicina, Universidade Federal de São Paulo
招募中
不适用
A comparison of radioactive iodine therapy versus anti-thyroid drugs as initial treatment for Graves diseaseCTRI/2016/03/006728Department of Internal Medicine90